Sign in with Google. Opens in new tab
Medical Development H1FY18 Results Largely In Line
180 Views19 Feb 2018 12:56
MEDICAL DEVELOPMENTS INTERNA (MVP AU) delivered its 2018 half-year results on Chinese New Year day, 16 February. Results were broadly in line with...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- LQ45 Index Rebalance Preview (Jul 2025): Identifying Potential Index Changes
- [Japan M&A] Polaris MBO for DD Group (3073) - Too Light But Probably a Done Deal
- HK-Listed Apparel & Footwear Screener July 2025: August 1st Deadline Approaches
- StubWorld: Absent Borrow, GMO Internet (4784) Is An Avoid
- GMO Internet (4784) - Shares Appear Manipulated/Squeezed (Again), but ParentCo MUST SELL
Top Unpaywalled Insights
More »Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Medical Development (MVP): Capital Raising and US Registration Reassurance06 Aug 2018
- Medical Development's Penthrox Trial in the US Is Placed on Clinical Hold - What's Next?25 Jul 2018
- Medical Development Warns Investors: Lower FY18 Revenue and Profit21 May 2018
- Medical Development H1FY18 Results Largely In Line19 Feb 2018
- The Opioid Battle: Nearing Crisis Point16 Nov 2017
x